Answers are grounded in this paper and cite their sources.
Recognition of transthyretin amyloid cardiomyopathy is increasing due to advances in cardiac imaging and diagnostic strategies, but questions remain regarding disease frequency and characteristics. We examined the prevalence and characteristics of transthyretin amyloid cardiomyopathy in older patients with hypertrophic cardiomyopathy of unascertained aetiology.
No takes yet. Share an insight, caveat, or question.
García‐Pavía et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: